Bristol Myers Squibb · Cash & Short-Term Investments

Latest reported$10.67Bperiod endingDec 31, 2025

BMY FY Cash & Short-Term Investments ($2.35B → $10.67B)

Annual Cash & Short-Term Investments

High-resolution chart · PNG

BMY cash & short-term investments history

Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Bristol Myers Squibb Cash & Short-Term Investments — Annual fiscal periods (USD)
Period ending	Cash & Short-Term Investments (USD)
Dec 31, 2025	10,673,000,000
Dec 31, 2024	10,859,000,000
Dec 31, 2023	12,280,000,000
Dec 31, 2022	9,253,000,000
Dec 31, 2021	17,221,000,000
Dec 31, 2020	16,450,000,000
Dec 31, 2019	15,393,000,000
Dec 31, 2018	8,759,000,000
Dec 31, 2017	6,812,000,000
Dec 31, 2016	6,350,000,000
Dec 31, 2015	4,270,000,000
Dec 31, 2014	7,435,000,000
Dec 31, 2013	4,525,000,000
Dec 31, 2012	2,829,000,000
Dec 31, 2011	8,733,000,000
Dec 31, 2010	7,301,000,000
Dec 31, 2009	8,514,000,000
Dec 31, 2008	8,265,000,000
Dec 31, 2007	2,225,000,000
Dec 31, 2006	4,013,000,000
Dec 31, 2005	5,799,000,000
Dec 31, 2004	7,474,000,000
Dec 31, 2003	5,562,000,000
Dec 31, 2002	3,989,000,000
Dec 31, 2001	5,654,000,000
Dec 31, 2000	3,385,000,000
Dec 31, 1999	2,957,000,000
Dec 31, 1998	2,244,000,000
Dec 31, 1997	1,456,000,000
Dec 31, 1996	1,681,000,000
Dec 31, 1995	1,645,000,000
Dec 31, 1994	1,642,000,000
Dec 31, 1993	2,421,000,000
Dec 31, 1992	2,137,000,000
Dec 31, 1991	1,435,000,000
Dec 31, 1990	596,000,000
Dec 31, 1989	510,000,000
Dec 31, 1988	2,512,000,000
Dec 31, 1987	2,347,000,000